With a robust clinical-stage pipeline, Agenus harnesses a mix of proprietary antibody platforms, like Retrocyte Exhibit™ and SECANT®, and revolutionary cell therapy techniques, positioning itself like a vital contributor within the biotechnology and immunotherapy arena.Retaining independence and editorial flexibility is important to our mission